Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Jan;67(1 Spec No):31–35. doi: 10.1136/adc.67.1_spec_no.31

Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate.

Y K Abu-Osba 1, O Galal 1, K Manasra 1, A Rejjal 1
PMCID: PMC1590342  PMID: 1536582

Abstract

Eight of nine newborn infants with severe persistent pulmonary hypertension of the newborn (PPHN), and a predicted mortality of 100%, and one infant with a predicted mortality greater than 94% based on alveolar-arterial oxygen tension difference [A-a)DO2) were treated with magnesium sulphate (MgSO4) as a life saving therapy after they failed to improve with conventional treatment. Magnesium at high serum concentrations decreases pulmonary pressures and is a muscle relaxant and sedative. Diluted MgSO4.7H2O solution (200 mg/kg) was given intravenously over 20-30 minutes. No changes in the treatment were made after MgSO4. Mean serum magnesium concentration was maintained between 2.88 and 5.67 mmol/l by continuous intravenous infusion (six infants). Baseline arterial oxygen tension (PaO2) and haemoglobin oxygen saturation had mean (SD) values of 4.66 (1.8) kPa and 60.4 (29.7)% respectively, which started to increase one hour after MgSO4 infusion, and increased significantly at six hours to 12.04 (7.07) kPa and 91.8 (10.88)% respectively. Arterial carbon dioxide tension (PaCO2) decreased and pH increased significantly after one hour compared with the baseline value. PaO2 increases are probably secondary to a decrease in pulmonary vascular resistance and pressure, decrease in a right to left shunt, better ventilation:perfusion ratio, and PaCO2 decrease and pH rise. Seven infants survived (77.8%). These results demonstrate the beneficial effect of magnesium in the management of PPHN when other accepted treatment fails, is contraindicated, or not available.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Osba Y. K. Treatment of persistent pulmonary hypertension of the newborn: update. Arch Dis Child. 1991 Jan;66(1 Spec No):74–77. doi: 10.1136/adc.66.1_spec_no.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altura B. T., Altura B. M. Interactions of Mg and K on cerebral vessels--aspects in view of stroke. Review of present status and new findings. Magnesium. 1984;3(4-6):195–211. [PubMed] [Google Scholar]
  3. Ayromlooi J., Desiderio D. M., Tobias M., Berg P. Effect of magnesium sulfate on maternal and fetal hemodynamics and fetal brain function and metabolism. Pediatr Pharmacol (New York) 1982;2(4):305–315. [PubMed] [Google Scholar]
  4. Bartlett R. H., Roloff D. W., Cornell R. G., Andrews A. F., Dillon P. W., Zwischenberger J. B. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985 Oct;76(4):479–487. [PubMed] [Google Scholar]
  5. Bohr D. F. The pulmonary hypoxic response. State of the field. Chest. 1977 Feb;71(2 Suppl):244–246. [PubMed] [Google Scholar]
  6. Briel R. C., Lippert T. H., Zahradnik H. P. Veränderungen von Blutgerinnung, Thrombozytenfunktion und vaskulärer Prostazyklinsynthese durch Magnesiumsulfat. Geburtshilfe Frauenheilkd. 1987 May;47(5):332–336. doi: 10.1055/s-2008-1035831. [DOI] [PubMed] [Google Scholar]
  7. Carter J. M., Gerstmann D. R., Clark R. H., Snyder G., Cornish J. D., Null D. M., Jr, deLemos R. A. High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure. Pediatrics. 1990 Feb;85(2):159–164. [PubMed] [Google Scholar]
  8. Clemens M. G., McDonagh P. F., Chaudry I. H., Baue A. E. Hepatic microcirculatory failure after ischemia and reperfusion: improvement with ATP-MgCl2 treatment. Am J Physiol. 1985 Jun;248(6 Pt 2):H804–H811. doi: 10.1152/ajpheart.1985.248.6.H804. [DOI] [PubMed] [Google Scholar]
  9. Cropp G. J. Reduction of hypoxic pulmonary vasoconstriction by magnesium chloride. J Appl Physiol. 1968 Jun;24(6):755–760. doi: 10.1152/jappl.1968.24.6.755. [DOI] [PubMed] [Google Scholar]
  10. Davis J. M., Spitzer A. R., Cox C., Fox W. W. Predicting survival in infants with persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 1988;5(1):6–9. doi: 10.1002/ppul.1950050103. [DOI] [PubMed] [Google Scholar]
  11. Dickstein P. J., Trindade O., Goldberg R. N., Bancalari E. The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. Pediatr Res. 1984 Dec;18(12):1262–1265. doi: 10.1203/00006450-198412000-00007. [DOI] [PubMed] [Google Scholar]
  12. Durlach J., Durlach V. Speculations on hormonal controls of magnesium homeostasis: a hypothesis. Magnesium. 1984;3(3):109–131. [PubMed] [Google Scholar]
  13. Dworetz A. R., Moya F. R., Sabo B., Gladstone I., Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics. 1989 Jul;84(1):1–6. [PubMed] [Google Scholar]
  14. Ebel H., Günther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem. 1980 May;18(5):257–270. doi: 10.1515/cclm.1980.18.5.257. [DOI] [PubMed] [Google Scholar]
  15. Fox W. W., Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr. 1983 Oct;103(4):505–514. doi: 10.1016/s0022-3476(83)80573-3. [DOI] [PubMed] [Google Scholar]
  16. Hageman J. R., Dusik J., Keuler H., Bregman J., Gardner T. H. Outcome of persistent pulmonary hypertension in relation to severity of presentation. Am J Dis Child. 1988 Mar;142(3):293–296. doi: 10.1001/archpedi.1988.02150030063021. [DOI] [PubMed] [Google Scholar]
  17. Howell R. E., Carrier G. O. Influence of magnesium on norepinephrine-and histamine-induced contractions of pulmonary vascular smooth muscle. Pharmacology. 1986;33(1):27–33. doi: 10.1159/000138196. [DOI] [PubMed] [Google Scholar]
  18. Krummel T. M., Greenfield L. J., Kirkpatrick B. V., Mueller D. G., Kerkering K. W., Ormazabal M., Napolitano A., Salzberg A. M. Alveolar-arterial oxygen gradients versus the Neonatal Pulmonary Insufficiency Index for prediction of mortality in ECMO candidates. J Pediatr Surg. 1984 Aug;19(4):380–384. doi: 10.1016/s0022-3468(84)80257-2. [DOI] [PubMed] [Google Scholar]
  19. Käpä P., Koivisto M., Ylikorkala O., Kouvalainen K. Prostacyclin in the treatment of neonatal pulmonary hypertension. J Pediatr. 1985 Dec;107(6):951–953. doi: 10.1016/s0022-3476(85)80200-6. [DOI] [PubMed] [Google Scholar]
  20. Lipsitz P. J. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics. 1971 Mar;47(3):501–509. [PubMed] [Google Scholar]
  21. Mathew R., Altura B. T., Altura B. M. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment. Magnesium. 1989;8(2):110–116. [PubMed] [Google Scholar]
  22. Miura K. [Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++--effects on the contractions of bovine cerebral artery]. No Shinkei Geka. 1988 Oct;16(11):1251–1259. [PubMed] [Google Scholar]
  23. Mroczek W. J., Lee W. R., Davidov M. E. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology. 1977 Oct;28(10):720–724. doi: 10.1177/000331977702801009. [DOI] [PubMed] [Google Scholar]
  24. Nadler J. L., Goodson S., Rude R. K. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension. 1987 Apr;9(4):379–383. doi: 10.1161/01.hyp.9.4.379. [DOI] [PubMed] [Google Scholar]
  26. Paidas C. N., Dudgeon D. L., Haller J. A., Jr, Clemens M. G. Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg. 1988 Dec;23(12):1154–1160. doi: 10.1016/s0022-3468(88)80332-4. [DOI] [PubMed] [Google Scholar]
  27. Philips J. B., 3rd, Lyrene R. K., McDevitt M., Perlis W., Satterwhite C., Cassady G. Prostaglandin D2 inhibits hypoxic pulmonary vasoconstriction in neonatal lambs. J Appl Physiol Respir Environ Exerc Physiol. 1983 Jun;54(6):1585–1589. doi: 10.1152/jappl.1983.54.6.1585. [DOI] [PubMed] [Google Scholar]
  28. Preclik G., Stange E. F., Gerber K., Fetzer G., Horn H., Ditschuneit H. Alimentary tract and pancreas. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut. 1989 Feb;30(2):148–151. doi: 10.1136/gut.30.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rasch D. K., Huber P. A., Richardson C. J., L'Hommedieu C. S., Nelson T. E., Reddi R. Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr. 1982 Feb;100(2):272–276. doi: 10.1016/s0022-3476(82)80654-9. [DOI] [PubMed] [Google Scholar]
  30. Short B. L., Miller M. K., Anderson K. D. Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol. 1987 Sep;14(3):737–748. [PubMed] [Google Scholar]
  31. Stone S. R., Pritchard J. A. Effect of maternally administered magnesium sulfate on the neonate. Obstet Gynecol. 1970 Apr;35(4):574–577. [PubMed] [Google Scholar]
  32. Turlapaty P. D., Altura B. M. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978 Dec 1;52(3-4):421–423. doi: 10.1016/0014-2999(78)90303-5. [DOI] [PubMed] [Google Scholar]
  33. Vacanti F. X., Ames A., 3rd Mild hypothermia and Mg++ protect against irreversible damage during CNS ischemia. Stroke. 1984 Jul-Aug;15(4):695–698. doi: 10.1161/01.str.15.4.695. [DOI] [PubMed] [Google Scholar]
  34. Watson K. V., Moldow C. F., Ogburn P. L., Jacob H. S. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1075–1078. doi: 10.1073/pnas.83.4.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weis M. T., Malik K. U. The influence of mono- and divalent cations on the cardiac metabolism of arachidonic acid. Prostaglandins. 1989 Jun;37(6):707–723. doi: 10.1016/0090-6980(89)90107-x. [DOI] [PubMed] [Google Scholar]
  36. White B. C., Winegar C. D., Wilson R. F., Krause G. S. Calcium blockers in cerebral resuscitation. J Trauma. 1983 Sep;23(9):788–794. doi: 10.1097/00005373-198309000-00003. [DOI] [PubMed] [Google Scholar]
  37. Wisner A., Bommelaer-Bayet M. C., Tiberghien C., Renard C. A., David F., Dray F. Hypothalamic prostaglandin E2 receptors coupled to an adenylyl cyclase. Eur J Pharmacol. 1989 Mar 14;162(1):89–100. doi: 10.1016/0014-2999(89)90607-9. [DOI] [PubMed] [Google Scholar]
  38. Wung J. T., James L. S., Kilchevsky E., James E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics. 1985 Oct;76(4):488–494. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES